Supreme Court Won't Hear Law Firm's Avandia Fund Dispute
By Matt Fair ( February 21, 2017, 4:27 PM EST) -- The U.S. Supreme Court said Monday it would not hear arguments following a Third Circuit decision forcing a law firm to set aside a share of proceeds into a common benefit fund after helping settle a batch of product liability suits in Illinois over GlaxoSmithKline PLC's diabetes drug Avandia....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.